Shen Yong-mei, Yang Xiao-chun, Dong Ning-zheng, Bai Xia
Radioimmunoassay Center, Second Affiliated Hospital, Soochow University, Suzhou, China.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Feb;25(2):150-4.
To generate and screen the specific Fab phage antibody library against human Daudi cell strain in B-lymphoma and identify the positive clones.
BALB/c mice were immunized with Daudi cells, and antisera were titrated by ELISA. Following the demonstration of sufficient antibody titer, total RNA was extracted from splenic lymphocytes of the immunized mice and RT-PCR was used to amplify kappa light chain and Fd fragments of heavy chain. After restrictive digestion with Sac I/Xba I and Xho I/Spe I, the kappa light chain and the Fd fragments were successively inserted into the phagemid vector pComb3H-SS and then electroporated into E.coli XL1-Blue. The specific Fab phage antibody library against Daudi cell strain in human B-lymphoma was constructed by infection of helper phage VCSM13. Following six rounds of biopanning with Daudi cells, the antigen binding activities of random clones were tested by ELISA to select the positive clones, which were further DNA sequenced, expressed in E.coli XL1-Blue and identified by Western blot.
The Fab phage antibody library with 3.13x10(7) size was constructed and four positive clones which specifically recognized Daudi cell strain were isolated. In amino acid sequences, the variable heavy domains (V(H)) were found to be 80%-02.394% and variable light domains (V(L)) 88%-95% homologous with respective murine germline genes in GenBank. Furthermore, soluble Fab antibodies of the positive clones were successfully expressed in E.coli XL1-Blue and the reactivity with the membrane proteins of Daudi cells was demonstrated by Western blot.
Fab phage antibody library is successfully constructed and specific antibodies against membrane antigens in Daudi cells are obtained, which provides an experimental foundation for the further investigation of B-lymphoma immunotherapy.
构建并筛选针对人B淋巴瘤Daudi细胞株的特异性Fab噬菌体抗体库,鉴定阳性克隆。
用Daudi细胞免疫BALB/c小鼠,ELISA法测定抗血清效价。在证实抗体效价足够后,从免疫小鼠的脾淋巴细胞中提取总RNA,用RT-PCR扩增κ轻链和重链Fd片段。经Sac I/Xba I和Xho I/Spe I限制性酶切后,将κ轻链和Fd片段依次插入噬菌粒载体pComb3H-SS,然后电穿孔导入大肠杆菌XL1-Blue。通过辅助噬菌体VCSM13感染构建针对人B淋巴瘤Daudi细胞株的特异性Fab噬菌体抗体库。用Daudi细胞进行六轮生物淘选后,通过ELISA检测随机克隆的抗原结合活性以筛选阳性克隆,对其进行进一步DNA测序,在大肠杆菌XL1-Blue中表达并通过Western印迹法鉴定。
构建了库容为3.13×10(7)的Fab噬菌体抗体库,分离出4个特异性识别Daudi细胞株的阳性克隆。在氨基酸序列中,可变重链区(V(H))与GenBank中相应小鼠种系基因的同源性为80%-102.394%,可变轻链区(V(L))为88%-95%。此外阳性克隆的可溶性Fab抗体在大肠杆菌XL1-Blue中成功表达,Western印迹法证明其与Daudi细胞膜蛋白有反应性。
成功构建了Fab噬菌体抗体库,获得了针对Daudi细胞表面抗原的特异性抗体,为进一步研究B淋巴瘤免疫治疗提供了实验基础。